Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 05 May 2021 for Ocugen, Inc., €1,876. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Vijay Tammara: trading record in brief
Vijay Tammara, listed as senior executive, appears in our data through filings on Ocugen, Inc. shares, published by SEC (Form 4). Between 29 April 2021 and 4 May 2021, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 5 May 2021 came the latest disclosure, an option exercise for €1,876 in Ocugen, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Vijay Tammara
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
4,900 shares@ US$0.4635.5% of flowCommon StockSEC:0001192482-21-000405:0
9,000 shares@ US$0.4664.5% of flowComm StockSEC:0001192482-21-000388:0
2 of 2 declarations
